Your browser doesn't support javascript.
loading
Characteristics of preventive intervention acceptance for international travel among clients aged 60 years and older from a Japanese multicenter pretravel consultation registry.
Yamamoto, Kei; Asai, Yusuke; Nakagawa, Hidenori; Nakatani, Issaku; Hayashi, Kenichi; Matono, Takashi; Kanai, Shinichiro; Yamato, Masaya; Mikawa, Takahiro; Shimatani, Michitsugu; Shimono, Nobuyuki; Shinohara, Koh; Kitaura, Tsuyoshi; Nagasaka, Atsushi; Manabe, Akihiro; Komiya, Nobuhiro; Imakita, Natsuko; Yamamoto, Yoshihiro; Iwamoto, Noriko; Okumura, Nobumasa; Ohmagari, Norio.
Affiliation
  • Yamamoto K; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan. Electronic address: kyamamoto@hosp.ncgm.go.jp.
  • Asai Y; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.
  • Nakagawa H; Department of Infectious Diseases, Osaka City General Hospital, Osaka, 534-0021, Japan.
  • Nakatani I; Travel Clinic, Nara Seibu Hospital, Nara, 631-0061, Japan.
  • Hayashi K; Department of Infectious Diseases, Kenwakai Otemachi Hospital, Kitakyushu, 803-0814, Japan.
  • Matono T; Department of Infectious Diseases, Aso Iizuka Hospital, Iizuka, 820-8505, Japan.
  • Kanai S; Department of Infection Control, Shinshu University Hospital, Matsumoto, 390-0802, Japan.
  • Yamato M; Department of General Medicine and Infectious Diseases, Travel Clinic, Rinku General Medical Center, Izumisano, 598-8577, Japan.
  • Mikawa T; Department of General Medicine and Infectious Diseases, Yamanashi Prefectural Central Hospital, Kofu, 400-0027, Japan.
  • Shimatani M; Department of Infectious Diseases, Hamamatsu Medical Center, Hamamatsu, 432-8580, Japan.
  • Shimono N; Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, 812-8582, Japan.
  • Shinohara K; Department of Infectious Diseases, Kyoto City Hospital, Kyoto, 604-8845, Japan.
  • Kitaura T; Division of Infectious Diseases, Faculty of Medicine, Tottori University, Yonago, 683-8504, Japan.
  • Nagasaka A; Department of Infectious Diseases, Sapporo City General Hospital, Sapporo, 060-8604, Japan.
  • Manabe A; Department of Clinical Laboratory Medicine, Fukuyama City Hospital, Fukuyama, 721-8511, Japan.
  • Komiya N; Department of Infectious Diseases, Japanese Red Cross Society Wakayama Medical Center, Wakayama, 640-8558, Japan.
  • Imakita N; Center for Infectious Diseases, Nara Medical University Hospital, Kashihara, 634-8522, Japan.
  • Yamamoto Y; Department of Clinical Infectious Diseases, Toyama University Hospital, Toyama, 930-0152, Japan.
  • Iwamoto N; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.
  • Okumura N; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.
  • Ohmagari N; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.
J Infect Chemother ; 29(12): 1137-1144, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37598777
ABSTRACT

OBJECTIVES:

Pretravel consultation (PTC) is important for older adults owing to health problems associated with overseas travel. Although older adults in Japan, their PTC characteristics are less known. This study aimed to investigate the epidemiology of clients aged ≥ 60 years based on data from the Japan Pre-travel Consultation Registry (J-PRECOR).

METHODS:

Clients aged ≥ 60 years who visited J-PRECOR cooperative hospitals from February 1, 2018, to May 31, 2022, were included. The primary endpoint was a comparison of prescriptions for vaccines for hepatitis A, tetanus toxoid, and malaria prophylaxis in travelers to high-risk malaria countries in yellow fever vaccination (YFV)-available facilities with and without YFV.

RESULTS:

In total, 1000 clients (median age 67 years) were included. Although 523 clients were immunized with YFV, only 38.6% of the 961 unimmunized clients were vaccinated with the tetanus toxoid-containing vaccine. Malaria chemoprophylaxis was prescribed to 25.7% of clients traveling for ≤55 days. At YFV-capable institutes, 557 clients traveling to yellow fever risk countries took PTC, 474 of whom received YFV and 83 were unvaccinated. Lower age (odds rate 0.85 per 1 year; 95% CI 0.80-0.90) and lower hepatitis A vaccination rate (0.29; 95% CI 0.14-0.63) were significantly associated with YFV.

CONCLUSIONS:

Preventive interventions other than YFV should be offered to older adults.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article